Navigation Links
PRA International Experts to Speak at Drug Safety Conference
Date:4/12/2011

RALEIGH, N.C., April 12, 2011 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that two experts from our Safety and Risk Management (SRM) group will speak at the World Drug Safety Congress being held in Boston, MA from 12-15 April 2011. PRA will also host an exhibit at booth #2.

Dr. Sabine Richter, PRA's Vice President of SRM, will chair the first breakout stream, "Operational Safety," on 13 April at 1:50 PM EDT.  Dr. Richter will provide opening remarks and moderate the session, which will address global safety regulatory intelligence, adverse event reporting and risks associated with missing data.

At 2:00 PM EDT, Dr. Kathleen Boyden, PRA's Director of Drug Safety Centers Americas, will deliver a presentation titled, "Adverse Event Monitoring and Global Safety Regulatory Intelligence."  Dr. Boyden will discuss strategies for maintaining global compliance, focusing specifically on relevant cultural, protocol and technological considerations associated with gathering and reporting adverse events.  

Dr. Richter has over 20 years of research experience in the pharmaceutical and CRO industries as well as in academia. Since joining PRA's SRM team in 2004, she has delivered numerous projects for a variety of clients and led large, long-term safety programs involving as many as 50 countries on five continents. As the head of PRA's SRM group, Dr. Richter has developed robust procedures and quality control measures to ensure consistent high performance and regulatory compliance.

Dr. Boyden has nearly 15 years of clinical research experience in academia and the CRO industry.  She joined PRA in 2007 as manager of Clinical Operations responsible for study start-up and legal services.  In 2003, Dr. Boyden earned a Ph.D. in nursing from the University of Virginia, where she conducted funded research as a National Institutes of Health Predoctoral Research Fellow.

Additional PRA
'/>"/>

SOURCE PRA International
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. HeartWare Announces Presentations at The International Society of Heart and Lung Transplantation Annual Meeting
2. Mauna Kea Technologies Announces Highlights of Third International Conference of Cellvizio Users (ICCU)
3. Two New U.S. Patents Issued to Dyadic International
4. Mindray Medical to Exhibit New Products at 65th China International Medical Equipment Fair
5. NuAire to Offer Adaptable Laboratory Centrifuges From Awel International
6. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
7. International Isotopes Inc. Announces 2010 Year End Financial Results
8. Ellman International Announces New US Sales Executive
9. SRI International Drug Candidate Shows Promise for Treating and Preventing Prostate Cancer
10. Nutraceutical International Corporation Launches Product Featuring ChromaDexs pTeroPure™ Pterostilbene
11. PRA International Experts to Chair BioPharma Asia Panels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 2014 Research and Markets  has ... Abuse Testing Markets (Lab-Based, Professional POC, Home, Employment, ... http://photos.prnewswire.com/prnh/20130307/600769 ... category in IVD testing with competitive participation by ... employers, criminal justice personnel, and sports use drug ...
(Date:8/1/2014)... 1, 2014  VanDeMark Chemical Inc., ... of phosgene and phosgene derivatives in ... has acquired Framochem Kft, a leading European-based manufacturer ... . The purchase unites two ... of the world,s largest, independent manufacturers of products ...
(Date:8/1/2014)... , Aug. 1, 2014 RoundTable ... focused exclusively on the healthcare industry, announced today ... The Lubrizol Corporation ("Lubrizol"). Lubrizol, a Berkshire Hathaway ... and supplies technologies to customers in the global ... transaction were not disclosed. Vesta is ...
Breaking Medicine Technology:Drugs of Abuse Testing Markets (Lab-Based, Professional POC, Home, Employment, Criminal Justice Markets) 2VanDeMark Chemical Inc. Acquires Framochem 2VanDeMark Chemical Inc. Acquires Framochem 3VanDeMark Chemical Inc. Acquires Framochem 4RoundTable Healthcare Partners Announces Sale of Vesta Funding, Inc. to The Lubrizol Corporation 2
(Date:8/1/2014)... research at Washington University School of Medicine in St. ... in males and frequently are more harmful than similar ... malignant brain tumors, are diagnosed twice as often in ... do not survive as long. , The researchers found ... cancer risk, is significantly less active in male brain ...
(Date:8/1/2014)... -- The U.S. Food and Drug Administration announced on ... help fight type 2 diabetes. Jardiance (empagliflozin) ... regimens to control blood sugar levels in the overall ... Office of Drug Evaluation II in the FDA,s Center ... statement. The FDA also recommended that Jardiance be ...
(Date:8/1/2014)... 2014 The evolving healthcare landscape ... pharmacies. At ThoughtSpot 2014, AmerisourceBergen and Good Neighbor ... and resources to enhance patient care and profitability. ... critical issues to give independent pharmacists the tools ... , ThoughtSpot show attendance experienced a nearly 70% ...
(Date:8/1/2014)... Growing prevalence of chronic ailments, ... are boosting healthcare market growth, although a reduction ... increasing generic consumption is a major challenge. , ... 2013, having grown at a Compound Annual Growth ... of the Health Transformation Program (Saglikta Donus, um ...
(Date:8/1/2014)... FRIDAY, Aug. 1, 2014 (HealthDay News) -- Patients with ... pulmonary disease (COPD) have a new weapon to battle ... Thursday. The agency approved a new treatment, ... the third leading killer of Americans. COPD, which is ... as chronic bronchitis and emphysema. Patients with ...
Breaking Medicine News(10 mins):Health News:Study reveals one reason brain tumors are more common in men 2Health News:FDA Approves New Type 2 Diabetes Drug 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 3Health News:ThoughtSpot 2014 Inspires as General Session Concludes 4Health News:ThoughtSpot 2014 Inspires as General Session Concludes 5Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4Health News:FDA Approves New Treatment for People With COPD 2
... at the Massachusetts Institute of Technology (MIT) has found ... ability to deform, and squeeze through tiny blood vessels ... the malaria-inducing parasite Plasmodium falciparum. ,The ... called RESA (ring-infected erythrocyte surface antigen), and found that ...
... the capital on Saturday. ,The Nigah Queer ... by many international directors. The films will be followed by ... of the programme is to give voice to the issue ... Code (IPC) is still in existence. Section 377 criminalizes private ...
... It seems that Hollywood hunk Brad Pitt is enjoying parental bliss ... the pregnant Myleene Klass at Cannes, Pitt poured his heart out ... have had your first scan yet? They're mind-blowing. Get ready to ... - it's the best thing that ever happened to me,' the ...
... new scare over soft drinks is in the making following revelations ... and Pepsi Max has the ability to switch off vital ... ,For when parts of DNA are disabled, as it were, it ... such as Parkinson's. ,Concerns centre on the safety of ...
... largest ever Parkinson's disease (PD) clinical trials to determine ... symptom progression of this disorder. ,PD is ... develop tremor, slowness of movements and stiffness of muscles. ... U.S. Currently, there are a number of effective treatments ...
... the way of administering the one effective drug, the ... in the USA, reports say . ,Stroke ... behind heart disease and cancer, killing 150,000 Americans a ... nation $62.7 billion, according to the American Stroke Association. ...
Cached Medicine News:Health News:Why Malaria Parasite Affects Red Blood Cells Deformability Revealed 2Health News:Gay Film Festival Begins in Delhi 2Health News:Soft Drink Additive Could Cause Cell Damage 2Health News:Soft Drink Additive Could Cause Cell Damage 3Health News:Emory Participates in Study to Slow Progression of Parkinson's Disease 2Health News:Lack of Timely Intervention Results in Needless Death Due to Stroke in US 2
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
For use with catalog #0454....
Medicine Products: